TTUHSC Garrison Institute
HomeCenters & InstitutesAging




GIA Photo


In 1999, TTUHSC leadership identified aging as a strategic priority for the 21st century. Formerly known as the Institute for Healthy Aging, the Garrison Institute on Aging honors Mildred and Shirley L. Garrison's commitment and leadership to advancing aging and Alzheimer's disease research, education, and service for West Texans...Learn More>>



 GIA Annual Report

Check out the newest edition of the
Garrison Institute on Aging's Annual Report!





April 4


"Mitochondria and Bioenergetics in Alzheimer's Disease"

Russell H. Swerdlow,M.D.
Gene and Marge Sweeney Professor Director
Alzheimer's Disease Center Director
Neurodegenerative Disease Program
Departments of Neurology, Molecular and Integrative Physiology, Biochemistry and Molecular Biology
University of Kansas Medical Center




Researchers from 9 institutions received funding from the Alzheimer's Association, including the Garrison Institute on Aging, Texas Tech University Health Sciences Center, Lubbock, Texas - check the website below for details of the press release.



Bridges Newsletter

Check out the newest addition of the GIA Bridges Newsletter



Special Issue 'Neurotransmitters and Alzheimer’s Disease' in Journal of Alzheimer’s Disease

 P. Hemachandra Reddy, Ph.D., will be bringing a special issue entitled ‘Neurotransmitters and Alzheimer’s Disease’ as a guest editor in Journal of Alzheimer’s Disease. The purpose of this special issue is to assess the recent developments in neurotransmitters research in order to improve our basic understanding of 1) neurotransmitters’ role in normal and Alzheimer’s disease states, 2) effect of oxidative insults and aging in causing abnormalities in neurotransmitters and synaptic damage, 3) amyloid beta and phosphorylated tau accumulations at synapses in causing abnormalities in neurotransmitters and synaptic damage, 4) development of therapeutic drugs that may enhance synaptic activity, neuronal function in AD neurons and 5) current status of pre-clinical and clinical trials using therapeutic drugs related to neurotransmitters in Alzheimer’s disease. This special issue will provide timely resources for students, clinical/basic science researchers, and Alzheimer’s disease patients and their families. The dates of submission will be open now until August 2016. If interested to submit an article for this special issue – please contact P. Hemachandra Reddy, Ph.D., – 



Download Free Adobe Reader Get Adobe Reader Adobe Acrobat Reader is required to view items marked with this icon:
Please click on the left image to download the free version.